Groupe Hospitalier Sud Ile-de-France   Report issue

Academic/Hospital Phase 3
Founded: Melun France (2017)

Organization Overview

First Clinical Trial
2020
NCT04235608
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CH Melun-Sénart